Skip to main content

Medical Information and Medical Affairs play a central role in the management of scientific information related to medicinal products. Although both functions operate within the medical domain, they differ in terms of responsibilities, objectives, and ways of working.

The distinction between these two areas is not always immediately clear. In many organizations, they work closely together and may even be part of the same department. Nevertheless, understanding their specific roles helps clarify information flows and highlights the contribution each function makes to the organization.

Medical Information: scientific support and inquiry management

Medical Information is responsible for managing scientific inquiries related to medicines and healthcare products from healthcare professionals, patients, and other stakeholders.

It is primarily an operational function that focuses on:

  • Providing accurate, balanced, and evidence-based responses;
  • Ensuring consistency and quality of the information communicated;
  • Managing complex inquiries, including those related to non-standard uses, while maintaining compliance with applicable requirements.

Medical Information operates mainly through a reactive approach. Responses are provided in response to specific questions, ensuring traceability, appropriateness, and alignment with company procedures.

Medical Affairs: a strategic and scientific function

Medical Affairs has a broader and more strategic role, aimed at supporting the appropriate use of medicines through scientific, clinical, and stakeholder-focused activities.

Key responsibilities typically include:

  • Defining the medical and scientific strategy for products;
  • Engaging with experts and Key Opinion Leaders (KOLs);
  • Managing medical networks through roles such as Medical Science Liaisons (MSLs);
  • Providing scientific support for clinical studies and research initiatives;
  • Conducting scientific exchange with healthcare professionals.

Unlike Medical Information, Medical Affairs follows a proactive approach. It contributes to the generation, interpretation, and dissemination of scientific knowledge while supporting evidence-based decision-making.

As a result, Medical Affairs serves as a critical link between clinical data, medical practice, and business strategy, always maintaining a non-promotional and scientifically grounded perspective.

Differences and complementarity between the two functions

On one side, Medical Information represents a more operational function focused on the structured management of inquiries and the delivery of consistent, traceable scientific information. On the other side, Medical Affairs provides a broader and more strategic perspective centered on data interpretation, scientific dialogue, and relationship-building within the medical community.

This distinction is also reflected in information flows. Medical Information often acts as the entry point for questions and information needs coming from the field, while Medical Affairs operates at a more integrated level, transforming these insights into knowledge that can support scientific initiatives, strategic decisions, and medical activities.

For example, when Medical Information receives recurring inquiries from healthcare professionals regarding a specific aspect of a medicinal product, such as its use in a particular patient population or the management of a specific adverse event, these inquiries may indicate an emerging information need. After being reviewed and documented according to internal procedures, the information can be shared with Medical Affairs. The Medical Affairs team may then evaluate it in light of the product’s medical strategy and guide potential scientific exchange activities, non-promotional educational materials, or medical education initiatives.

Consequently, the two functions operate as parts of an interconnected system. The accuracy and reliability of the content managed by Medical Information supports the work of Medical Affairs, while Medical Affairs helps shape priorities and scientific messaging based on clinical insights and evolving medical needs.

Conclusions

Medical Information and Medical Affairs perform distinct yet complementary roles within pharmaceutical companies. Medical Information ensures the quality, accuracy, and traceability of scientific responses, whereas Medical Affairs leverages scientific evidence from a broader strategic perspective.

The integration of these functions supports the appropriate and safe use of medicines through the effective and responsible management of scientific information.

References

  1. European Federation of Pharmaceutical Industries and Associations (EFPIA) – Guidelines on Medical Information
  2. International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) – Code of Practice
  3. European Medicines Agency (EMA) – Guidance on Scientific Information Exchange and Interactions with Healthcare Professionals
  4. Association of the British Pharmaceutical Industry (ABPI) – Code of Practice for the Pharmaceutical Industry
  5. MAPS (Medical Affairs Professional Society) – Medical Affairs Competency Framework
  6. DIA (Drug Information Association) – Medical Affairs and Medical Information Best Practices